Search
Benserazide
go.drugbank.com/drugs/DB12783ApprovedInvestigationalA decarboxylase inhibitor like benserazide is consequently an effective compound to combine with levadopa as it is incapable of crossing the blood-brain barrier itself but acts to prevent the formation
Mixtures: LEVOBENS TEVA 100MG/25MG, RESTEX 100MG/25MG RETARDIEBacitracin
go.drugbank.com/drugs/DB00626ApprovedInvestigationalVet approvedBacitracin is a combination of at least 9 bacitracins.[A955,A181952] 60-80% of commercially prepared bacitracin is bacitracin A.
Mixtures: WELL AT WALG TRIPLE ANTIBIOTIC Well at WalgreensProducts: ZAMBAC MD SOLUBLE 50g/100g bacitracin methylene disalicylateMannitol
go.drugbank.com/drugs/DB00742ApprovedInvestigationalMannitol is an osmotic diuretic that is metabolically inert in humans and occurs naturally, as a sugar or sugar alcohol, in fruits and vegetables. Mannitol elevates blood plasma osmolality, resulting in enhanced flow of water from tissue...
Products: MANITOL AL 20 % EN AGUA DESTILADA, MANITOL AL 20% EN AGUA DESTILADADeflazacort
go.drugbank.com/drugs/DB11921ApprovedIt is marketed by Marathon Pharmaceuticals and was approved in February 2017 by the FDA.
Products: AVANTIUM 30MG TABLETAS, DEFLAZACORT EGTucatinib
go.drugbank.com/drugs/DB11652ApprovedInvestigationalIt was developed by Seattle Genetics and approved by the FDA on April 17, 2020. … Tucatinib is a kinase inhibitor drug used with [trastuzumab] and [capecitabine] in the treatment of unresectable or metastatic HER-2 positive breast cancer.
Non-erosive Reflux Esophagitis Disease (NERD)
go.drugbank.com/conditions/DBCOND0071254Insulin aspart
go.drugbank.com/drugs/DB01306ApprovedInvestigationalCompared to human insulin, it has a single amino acid substitution at position B28 where proline is replaced with aspartic acid. … This substitution decreases its propensity to form hexamers and gives it a higher rate of absorption following subcutaneous administration compared to native insulin.
Products: Fiasp® 100 units/ml, 10ml VialCabazitaxel
go.drugbank.com/drugs/DB06772ApprovedInvestigationalIt was first approved by the FDA on June 17, 2010.[A260421] It was also approved by the EMA on March 17, 2011 [L47381] and Health Canada on December 17, 2019.[L47376]
Products: CABAZITAXEL EG, XITACAB® 60MG/1.5ML (40MG/ML)Levosimendan
go.drugbank.com/drugs/DB00922ApprovedInvestigationalWithdrawnIt also relaxes vascular smooth muscle by opening adenosine triphosphate sensitive potassium channels. Levosimendan is used to manage acutely decompensated congestive heart failure.
Products: LEVOSIMENDAN EGCholestyramine
go.drugbank.com/drugs/DB01432ApprovedInvestigationalCholestyramine or colestyramine is a bile acid sequestrant. Bile acid sequestrants are polymeric compounds which serve as ion exchange resins. Cholestyramine resin is quite hydrophilic, but insoluble in water.
Products: ANTILIP GRANULADO EN SACHET